How biosimilars and generics can deliver better value for the NHS
Read our explainer on biosimilars and generics and the potential benefits they can offer.
Our in-depth articles explore how our work is making a real difference to people's lives.
Read our explainer on biosimilars and generics and the potential benefits they can offer.
As Sam Roberts prepared to hand over the baton as chief executive, she reflected on her time at NICE and looked to the next chapter for the organisation. She also reflected on our 2025 highlights and achievements in delivering our transformation plan and our commitments in the 10 Year Plan.
NICE is poised to deliver key commitments in the government’s 10 Year Plan for health and care. We’re delighted by the plan’s endorsement of our role in delivering faster, and fairer access to the best innovations. It will strengthen our position in the system, guided by our core purpose.
Our annual report and accounts summarise our key achievements from April 2024 to March 2025.
NICE International has helped Egypt take a crucial step towards a fairer, more efficient healthcare system.
An end of year summary from our chief executive, Dr Sam Roberts.
Page 1 of 5